HIM
IDXX icon

Hillsdale Investment Management’s Idexx Laboratories IDXX Stock Holding History

Hillsdale Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,940
Closed -$484K – 612
2018
Q3 		$484K Hold
1,940
– – 0.06% 181
2018
Q2 		$423K Sell
1,940
-20
-1% -$4.12K 0.05% 220
2018
Q1 		$375K Sell
1,960
-200
-9% -$36.9K 0.05% 238
2017
Q4 		$337K Hold
2,160
– – 0.05% 276
2017
Q3 		$336K Sell
2,160
-200
-8% -$31.6K 0.06% 265
2017
Q2 		$381K Sell
2,360
-320
-12% -$52K 0.07% 204
2017
Q1 		$414K Sell
2,680
-300
-10% -$41.4K 0.08% 183
2016
Q4 		$349K Hold
2,980
– – 0.07% 202
2016
Q3 		$336K Buy
+2,980
New +$314K 0.09% 236

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hillsdale Investment Management's IDXX Position: Q4 2018 in Review

Hillsdale Investment Management sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 1,940 shares — an estimated $484K sold.

Hillsdale Investment Management first reported a position in IDXX in Q3 2016 and held it in 9 quarters. The position peaked at $484K in Q3 2018. 671 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

  • Hillsdale Investment Management reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
  • Hillsdale Investment Management sold 1,940 Idexx Laboratories shares in Q4 2018, an estimated $484K.
  • Hillsdale Investment Management first reported a position in Idexx Laboratories in Q3 2016 and held it in 9 quarters.
  • Hillsdale Investment Management's Idexx Laboratories position peaked at $484K in Q3 2018.
  • 671 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Hillsdale Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.